Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR study.

Diego Santos GarcíaIria Cabo LópezCarmen Labandeira GuerraRosa Yáñez BañaMaria I Cimas HernandoJose M Paz GonzálezMaria G Alonso LosadaMaria J Gonzalez PalmásCarlos Cores BartoloméCristina Martínez Miró

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

Safinamide was well-tolerated and improved sleep and daytime sleepiness in PD patients at 6 months.

Keyphrases

sleep quality
obstructive sleep apnea
depressive symptoms
physical activity
positive airway pressure
sleep apnea